Information  X 
Enter a valid email address

BARCLAYS PLC (0Y4Q)

  Print      Mail a friend

Tuesday 23 February, 2021

BARCLAYS PLC

Form 8.3 - Willis Towers Watson plc

Form 8.3 - Willis Towers Watson plc

BARCLAYS PLC

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 22 February 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

2,035,439

1.58%

383,076

0.30%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

153,127

0.12%

240,989

0.19%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,000

0.00%

6,000

0.00%

 

 

 

 

TOTAL:

 

 

 

 

2,194,566

1.70%

630,065

0.49%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

1

225.0000 USD

Purchase

7

225.1828 USD

Purchase

7

225.0786 USD

Purchase

11

224.9400 USD

Purchase

25

225.3900 USD

Purchase

40

225.3600 USD

Purchase

50

225.3800 USD

Purchase

89

225.4496 USD

Purchase

100

224.8600 USD

Purchase

121

225.3205 USD

Purchase

144

224.9165 USD

Purchase

150

225.0266 USD

Purchase

169

225.2630 USD

Purchase

199

225.3590 USD

Purchase

300

225.3500 USD

Purchase

400

225.1587 USD

Purchase

586

225.1299 USD

Purchase

952

224.9192 USD

Purchase

994

224.9456 USD

Purchase

994

224.9455 USD

Purchase

1,200

225.2399 USD

Purchase

2,530

225.1243 USD

Purchase

2,907

225.1740 USD

Purchase

3,783

225.1634 USD

Purchase

7,419

225.1151 USD

Purchase

12,824

225.2428 USD

Purchase

13,240

225.0212 USD

Purchase

13,618

225.0062 USD

Purchase

28,276

225.0324 USD

Purchase

102,625

224.9004 USD

Purchase

108,853

224.9000 USD

Sale

1

225.2800 USD

Sale

1

225.2600 USD

Sale

2

225.1700 USD

Sale

25

225.3900 USD

Sale

49

224.9500 USD

Sale

87

225.4600 USD

Sale

100

224.9900 USD

Sale

100

224.7300 USD

Sale

100

224.8100 USD

Sale

200

225.1900 USD

Sale

238

224.7843 USD

Sale

256

225.5798 USD

Sale

294

224.8823 USD

Sale

302

225.1451 USD

Sale

437

225.1458 USD

Sale

488

224.9858 USD

Sale

493

224.9178 USD

Sale

700

224.9721 USD

Sale

710

225.1486 USD

Sale

916

224.9789 USD

Sale

952

224.9192 USD

Sale

994

224.9455 USD

Sale

1,037

224.9839 USD

Sale

1,200

225.2399 USD

Sale

1,369

224.9023 USD

Sale

1,820

225.0701 USD

Sale

3,124

225.1192 USD

Sale

4,295

225.1032 USD

Sale

4,927

224.9272 USD

Sale

5,839

224.8999 USD

Sale

8,326

224.9723 USD

Sale

10,000

225.1619 USD

Sale

10,352

225.1347 USD

Sale

11,723

225.0187 USD

Sale

12,669

224.9952 USD

Sale

12,845

225.2718 USD

Sale

102,476

224.9000 USD

Sale

102,626

224.9004 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

23 Feb 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name

Written or 

Number of

Exercise

Type

Expiry

 

purchased

relevant securities 

price

 

date

 

 

to which the option 

 

 

 

 

 

or derivative 

 

 

 

 

 

relates

 

 

 

Call Options

  Purchased

6,000

220.0000 

American

Jul 16, 2021

Put Options

  Purchased

-6,000

200.0000 

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.


a d v e r t i s e m e n t